Privacy advocates are concerned over plans for genetic testing company 23andMe to be made public through a partnership with a company backed Richard Branson. “The question in all situations like this is where the data is going and why these different companies and investors have a financial interest in your genetic data,” said Jennifer King, Stanford Institute for Human-Centered AI who has studied 23andMe.
What is this page?
You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.
The Privacy Newsfeed monitors over 300 global publications, of which more than 5,750 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.
